Font Size

SCREEN

Profile

Direction

Menu Style

  Return to Menu

ABSTRACT SUBMISSION


Abstracts are invited on the following topics           SUBMIT ABSTRACT
    • Viral targets (pre-clinical)
    • Pre-clinical development of antivirals and immune-therapeutics
    • Host-Directed Antiviral Therapeutics 
    • Surveillance & Antiviral Resistance
    • Antivirals, Monoclonal Antibodies and Combinations in the clinical setting
    • Human challenge studies and new clinical trial designs

Abstract submission deadline: midnight, US Pacific time, 3 March 2023

ENQUIRIES: Please email: lidadesouza@isirv.org